Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) EBT (2017 - 2025)

Neuronetics (STIM) has disclosed EBT for 9 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • Quarterly EBT rose 46.88% to -$7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$39.5 million through Dec 2025, up 6.18% year-over-year, with the annual reading at -$39.9 million for FY2025, 4.77% up from the prior year.
  • EBT for Q4 2025 was -$7.4 million at Neuronetics, up from -$9.3 million in the prior quarter.
  • The five-year high for EBT was -$6.3 million in Q4 2023, with the low at -$13.9 million in Q4 2024.
  • Average EBT over 5 years is -$9.4 million, with a median of -$9.1 million recorded in 2022.
  • The sharpest move saw EBT crashed 147.58% in 2021, then surged 46.88% in 2025.
  • Over 5 years, EBT stood at -$8.0 million in 2021, then fell by 10.71% to -$8.8 million in 2022, then grew by 28.96% to -$6.3 million in 2023, then crashed by 120.99% to -$13.9 million in 2024, then soared by 46.88% to -$7.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$7.4 million, -$9.3 million, and -$9.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.